KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Inventory (2016 - 2025)

Bausch Health Companies' Change in Inventory history spans 17 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 89.8% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $12.0 million, down 95.51%, while the annual FY2025 figure was $12.0 million, 95.51% down from the prior year.
  • Change in Inventory for Q4 2025 was $5.0 million at Bausch Health Companies, up from -$16.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $144.0 million in Q1 2024 and bottomed at -$46.0 million in Q4 2021.
  • The 5-year median for Change in Inventory is $33.5 million (2021), against an average of $40.8 million.
  • The largest annual shift saw Change in Inventory surged 2400.0% in 2023 before it plummeted 138.1% in 2025.
  • A 5-year view of Change in Inventory shows it stood at -$46.0 million in 2021, then surged by 108.7% to $4.0 million in 2022, then soared by 2400.0% to $100.0 million in 2023, then plummeted by 51.0% to $49.0 million in 2024, then tumbled by 89.8% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Change in Inventory are $5.0 million (Q4 2025), -$16.0 million (Q3 2025), and -$7.0 million (Q2 2025).